SIR-Variations in the gene encoding the serotonin transporter (5-HTT), which regulates reuptake of brain serotonin (5-HT), are thought to affect the levels of 5-HT in the brain. This study reports that LS/SS variants of the human 5-HTT gene (SLC6A4) are associated with increased 5-HT 1A receptor binding in cingulate brain regions in healthy women (HW) .
A functional polymorphism in the promoter region of the human 5-HTT gene (SLC6A4) has been implicated in the modulation of mood and antidepressant response. 1 Several lines of evidence show that the genotype with two copies of the long (L, 528 bp) allele leads to greater 5-HT reuptake compared to genotypes having either one or two copies of the short (S, 484 bp) allele.
2 Since 5-HTT regulates 5-HT concentrations in the synaptic cleft by recycling released 5-HT, individuals with the S allele are likely to have higher extracellular 5-HT concentrations during neurodevelopment and, possibly, in the mature 5-HT system. The activity of the 5-HTT is thought to influence the 5-HT 1A receptor. For example, chronic administration of serotonin reuptake inhibitors (SRIs) leads to a desensitization of 5-HT 1A autoreceptors. 3 However, to our knowledge, no studies have investigated the relationship of this 5-HTT polymorphism to 5-HT 1A receptor binding in vivo in healthy subjects.
In all, 16 HW were recruited as described previously. 4 HW had no history of any psychiatric, medical, or neurological illness and were not taking any relevant medication. This study was conducted according to local institutional review board regulations, and all subjects gave written informed consent. PET imaging was performed during the first 10 days of the follicular phase of the menstrual cycle. PET and [carbonyl- 11 C]WAY100635 methods have been described previously. 5 Dynamic PET scanning was performed over a period of 60 or 90 min with arterial blood sampling. The longer 90 min acquisition was collected in 11 HW. For the arterial-based kinetic analyses, regional [ 11 C]WAY100635 distribution volume (DV) values were determined using a modified Logan graphical method 6 after smoothing of the data. The Logan analysis was performed over 25-60 min (seven points) and over 25-90 min (10 points) for the 60 and 90 min comparative analyses, respectively. The specific binding potential (BP) measure was determined as BP ¼ DV Region of Interest ÀDV Cerebellum 7 in prefrontal, lateral and medial orbital frontal, cingulate, mesial and lateral temporal, and parietal cortices as well as in the dorsal raphe.
S and L alleles were determined using DNA amplification (PCR) and established flanking primers. Amplification products were resolved by electrophoresis and visualized with ethidium bromide staining and UV transillumination, according to Edenberg and Reynolds. 8 The 16 HW were 25.0 (SD 6.0) years old (range 18.6-39.9) and had a body mass index of 22.3 kg/m 2 (SD 2.1) (range 18.7-26.3). High correlations were observed between the cerebellar DV and regional BP measures calculated using the 60 and 90 min data sets (r ¼ 0.96-0.99), supporting the validity of the results obtained using the 60 min data set. The sample showed allele frequencies of 59% for the L allele and 41% for the S allele with a genotype distribution of 37.5% LL, 43.7% LS, and 18.8% SS, which is in accordance with a larger predominantly North American-European population. These data suggest that the LS/SS genotypes, which presumably are associated with greater extracellular 5-HT concentrations, at least during early developmental periods, are associated with increased postsynaptic 5-HT 1A receptor density in HW, as indexed by [ 11 C]WAY100635 BP, in subregions of the anterior cingulate cortex, and possibly other cortical regions, but not the raphe. Autoreceptor 5-HT 1A activation is thought to be a negative feedback mechanism that reduces raphe activity. 10 Recent studies show that postsynaptic 5-HT 1A receptors, in frontal regions, have inhibitory properties through feedback loops on raphe activity. 11 Perhaps, increased activity of the postsynaptic 5-HT 1A receptor is part of the homeostatic mechanisms that serve to counterbalance increased extracellular 5-HT concentrations in HW. Alternatively, increased postsynaptic 5-HT 1A availability may represent a homeostatic response to reduced 5-HT tone resulting from developmental changes (eg reduction of 5-HT fibers and/or raphe firing 12 associated with initially increased 5-HT availability in 5-HTTLPR short allele carriers).
We assessed the naturalistic relationships of genetic variation presumably resulting in altered 5-HTT availability. Experimental paradigms, which involve massive manipulations of a homeostatic system in animals, have different findings. 5-HTT knockout mice show reduced density of 5-HT 1A receptors in the raphe, and some nuclei of the hypothalamus, amygdala, and septum. 13 Rodents chronically treated with SRIs 14, 15 have desensitization of 5-HT 1A receptors in the raphe and hypothalamus, but not the hippocampus or cortex. Together, these data suggest that 5-HT 1A receptor response is region specific and may also be influenced by gender. 13, 16 5-HT 1A receptors and the 5-HTT are part of a complex 5-HT neuronal pathway involving many other receptors, intracellular cascades, enzymes, and other components. It is likely that different paradigms have different functional effects on these many elements that contribute to neuronal activity.
Finally, in support of these findings, others have found that individuals with SS or LS genotypes exhibit greater amygdala neuronal activity in response to salient stimuli, in comparison to individuals with LL genotype. 17 It is possible that an increase in 5-HT 1A receptor density associated with SS/LS genotype may inhibit function of the anterior cingulate, a region that normally serves to inhibit amygdala reactivity, 18 thus contributing to heightened amygdale response. 
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